Synaptogenix Inc (SNPX)
4.61
+0.24
(+5.49%)
USD |
NASDAQ |
Jun 14, 16:00
4.61
0.00 (0.00%)
After-Hours: 20:00
Synaptogenix Enterprise Value: -21.76M for June 14, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 14, 2024 | -21.76M |
| June 13, 2024 | -22.06M |
| June 12, 2024 | -22.03M |
| June 11, 2024 | -22.26M |
| June 10, 2024 | -22.31M |
| June 07, 2024 | -22.30M |
| June 06, 2024 | -22.30M |
| June 05, 2024 | -22.31M |
| June 04, 2024 | -22.09M |
| June 03, 2024 | -21.77M |
| May 31, 2024 | -21.83M |
| May 30, 2024 | -21.97M |
| May 29, 2024 | -22.03M |
| May 28, 2024 | -21.78M |
| May 24, 2024 | -21.88M |
| May 23, 2024 | -21.67M |
| May 22, 2024 | -21.49M |
| May 21, 2024 | -21.34M |
| May 20, 2024 | -21.48M |
| May 17, 2024 | -21.59M |
| May 16, 2024 | -21.39M |
| May 15, 2024 | -21.64M |
| May 14, 2024 | -21.57M |
| May 13, 2024 | -21.87M |
| May 10, 2024 | -22.48M |
| Date | Value |
|---|---|
| May 09, 2024 | -22.33M |
| May 08, 2024 | -22.40M |
| May 07, 2024 | -22.36M |
| May 06, 2024 | -22.33M |
| May 03, 2024 | -21.92M |
| May 02, 2024 | -22.28M |
| May 01, 2024 | -22.20M |
| April 30, 2024 | -22.30M |
| April 29, 2024 | -22.61M |
| April 26, 2024 | -22.53M |
| April 25, 2024 | -22.65M |
| April 24, 2024 | -22.50M |
| April 23, 2024 | -22.48M |
| April 22, 2024 | -22.71M |
| April 19, 2024 | -22.74M |
| April 18, 2024 | -22.39M |
| April 17, 2024 | -22.23M |
| April 16, 2024 | -22.40M |
| April 15, 2024 | -22.65M |
| April 12, 2024 | -22.36M |
| April 11, 2024 | -22.21M |
| April 10, 2024 | -22.34M |
| April 09, 2024 | -22.08M |
| April 08, 2024 | -21.59M |
| April 05, 2024 | -22.02M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-28.87M
Minimum
Mar 22 2023
52.91M
Maximum
Oct 12 2021
-0.2335M
Average
5.271M
Median
Feb 05 2021
Enterprise Value Benchmarks
| CEL-SCI Corp | 65.10M |
| AIM ImmunoTech Inc | 15.35M |
| IGC Pharma Inc | 25.36M |
| NovaBay Pharmaceuticals Inc | 3.382M |
| Protalix BioTherapeutics Inc | 55.51M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.2067M |
| Total Expenses (Quarterly) | 1.692M |
| EPS Diluted (Quarterly) | -0.41 |
| Earnings Yield | -806.6% |